MarketCap
Immuron Limited IMRN
€ 0.86
-0.01%
Facebook
X
Telegram
Immuron Limited DSO | IMRN
DSO Jährlich Immuron Limited
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 148 | 333 | 462 | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in AUD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 462 | 148 | 315 |
DSO anderer Aktien in der Pharmaeinzelhändler
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Bristol-Myers Squibb Company
BMY
|
83.9 | $ 61.57 | 0.15 % | $ 125 B |  USA |
 |
Novartis AG
NVS
|
0.045 | $ 153.93 | 1.86 % | $ 298 B |  Schweiz |
 |
Ocular Therapeutix
OCUL
|
221 | $ 6.49 | -0.23 % | $ 1.22 B | USA |
 |
Oragenics
OGEN
|
6.55 | $ 0.4 | -3.86 % | $ 863 K | USA |
 |
Checkpoint Therapeutics
CKPT
|
6.83 | - | - | $ 169 M | USA |
 |
Omeros Corporation
OMER
|
115 | $ 16.27 | -1.81 % | $ 1.03 B | USA |
 |
Outlook Therapeutics
OTLK
|
192 | $ 0.51 | -1.71 % | $ 17.7 M | USA |
 |
Ovid Therapeutics
OVID
|
4.1 | $ 2.15 | -0.23 % | $ 280 M | USA |
 |
Sage Therapeutics
SAGE
|
408 | - | - | $ 527 M | USA |
 |
Taro Pharmaceutical Industries Ltd.
TARO
|
143 | - | - | $ 1.62 B |  Israel |
 |
Nuvation Bio
NUVB
|
83.6 | $ 4.5 | -1.53 % | $ 1.54 B | USA |
 |
Puma Biotechnology
PBYI
|
68.5 | $ 10.85 | -1.54 % | $ 543 M | USA |
 |
Processa Pharmaceuticals
PCSA
|
7.47 | $ 1.76 | -2.76 % | $ 2.3 M | USA |
 |
Forma Therapeutics Holdings
FMTX
|
5.57 | - | - | $ 958 M | USA |
 |
Blueprint Medicines Corporation
BPMC
|
42.5 | - | - | $ 8.14 B | USA |
 |
Pfizer
PFE
|
68.1 | $ 29.8 | -0.78 % | $ 169 B | USA |
 |
Horizon Therapeutics Public Limited Company
HZNP
|
65.8 | - | - | $ 26.6 B |  Irlanda |
|
Phathom Pharmaceuticals
PHAT
|
122 | $ 5.94 | 3.48 % | $ 433 M | USA |
 |
Paratek Pharmaceuticals
PRTK
|
119 | - | - | $ 121 M | USA |
 |
Pliant Therapeutics
PLRX
|
229 | $ 0.85 | -1.64 % | $ 52.2 M | USA |
 |
Adverum Biotechnologies
ADVM
|
222 | - | - | $ 86.2 M | USA |
 |
Prothena Corporation plc
PRTA
|
6.97 | $ 8.38 | 2.2 % | $ 451 M | USA |
 |
PTC Therapeutics
PTCT
|
35.9 | $ 61.04 | 0.74 % | $ 4.85 B | USA |
 |
Protagonist Therapeutics
PTGX
|
10.7 K | $ 140.24 | 1.31 % | $ 8.92 B | USA |
 |
Pulmatrix
PULM
|
21.7 | $ 1.44 | -2.7 % | $ 5.26 B | USA |
 |
Seelos Therapeutics
SEEL
|
63.2 | - | -47.76 % | $ 6.27 M | USA |
 |
Advaxis
ADXS
|
3.28 K | - | -9.65 % | $ 45.9 M | USA |
 |
Atossa Therapeutics
ATOS
|
207 | $ 2.45 | -5.91 % | $ 21.1 M | USA |
 |
Ultragenyx Pharmaceutical
RARE
|
75.9 | $ 16.09 | 2.78 % | $ 1.59 B | USA |
 |
Arcus Biosciences
RCUS
|
3.21 | $ 17.7 | -4.53 % | $ 1.9 B | USA |
 |
RedHill Biopharma Ltd.
RDHL
|
358 | $ 0.43 | 0.57 % | $ 5.3 B | Israel |
 |
Regeneron Pharmaceuticals
REGN
|
152 | $ 808.08 | 0.38 % | $ 84.5 B | USA |